Sc Ii Acquisition Corp. (SCII) Stock Price & Analysis
Sc Ii Acquisition Corp. (SCII) rose 0.00% to USD 10.04 as of June 10, 2026 at 09:02 UTC, according to Nexqual real-time market data.
SCII last closed at USD 10.04; the session ranged USD 10.04–10.04 on volume of 5 shares. Market capitalization is $249.97M, with a 52-week range of USD 9.9–10.07 (NGM). Source: Nexqual, June 10, 2026 at 09:02 UTC.
Key Statistics (as of June 10, 2026 at 09:02 UTC)
| Price | USD 10.04 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.04 |
| Open | USD 0 |
| Day Range | USD 10.04 – 10.04 |
| 52-Week Range | USD 9.9 – 10.07 |
| Volume | 5 shares |
| Market Cap | $249.97M |
| Exchange | NGM |
Technical Analysis (SCII)
Nexqual's technical model rates SCII "STRONG BUY" based on 5 bullish and 0 bearish signals across 97 daily candles, as of June 10, 2026 at 09:02 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.44 (neutral) |
| vs SMA50 | Above (USD 10) |
| MACD | 0.01 (positive) |
Analyst Ratings (SCII)
Wall Street analysts rate SCII "None", per Nexqual as of June 10, 2026 at 09:02 UTC.
| Consensus Rating | None |
|---|
Earnings (SCII)
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financials & Fundamentals (SCII)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 4.77 |
| Total Debt | $137,595 |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financial Health Score (SCII)
Nexqual rates Sc Ii Acquisition Corp.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:02 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Weak — Operating cash flow -$497K |
| Efficiency | Mixed — No data |
Ownership (SCII)
| Insider Ownership | +5.71% |
|---|---|
| Institutional Ownership | +89.70% |
| Shares Outstanding | 17.50M |
| Float | 17.25M |
| Short % of Float | +0.01% |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Leadership (SCII)
Sc Ii Acquisition Corp. is led by Menachem Shalom (age 49), CEO & Chairman, per Nexqual as of June 10, 2026 at 09:02 UTC.
| CEO & Chairman | Menachem Shalom (age 49) |
|---|---|
| Chief Financial Officer | Asaf Yarkoni (age 50) |
Major Backers & Investors (SCII)
Notable institutional backers of Sc Ii Acquisition Corp. include Karpus Management, Inc., Linden Advisors LP, Glazer Capital LLC, according to Nexqual as of June 10, 2026 at 09:02 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Karpus Management, Inc. | 17.29% |
| Linden Advisors LP | 8.56% |
| Glazer Capital LLC | 8.37% |
| Shaolin Capital Management LLC | 4.86% |
| First Trust Capital Management L.P. | 3.97% |
| INVESTMENT MANAGERS SERIES TRUST II-First Trust Merger Arbitrage Fund | 3.84% |
| Mizuho Securities USA LLC | 2.98% |
| Westchester Capital Management, LLC | 2.86% |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
From Sc Ii Acquisition Corp.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- SC II Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ISCO | International Stem Cell Corp. | USD 0.17 | ▼ 5.56% |
| SCAL | Stem Cell Authority, Ltd. | USD 0 | ▲ 0% |
| POCI | Precision Optics Corporation, I | USD 5.68 | ▼ 2.07% |
| MCOM | Micromobility.com Inc. | USD 0.01 | ▲ 25% |
| MCET | MULTICELL TECHNOLOGIES INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:02 UTC. This page is informational and not investment advice.